GCK and Hyperglycemia: On the contrary, other authors have shown that the active ingredient of FS, diosgenin, is the most important agent that reduces fasting hyperglycemia in diabetic animals promoting the β-cells generation, inhibiting hepatic gluconeogenesis, and stimulating liver glycolysis (hepatic glucokinase) [55,56].